ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
ABIONYX PHARMA: ifrs:AdjustmentsForDepreciationAndAmortisationExpense
One fact, its scope and the complete path back to the official record.
Reported value
126.000k{"amount": 126000.0}- Entity
- ABIONYX PHARMA
- Metric
- ifrs:AdjustmentsForDepreciationAndAmortisationExpense
- Period
- 2025-01-01 – 2025-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:969500785J7VIC5YPC96:2025-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T22:42:18.659153+02:00
Raw response SHA-256
df7f82c289c957874561346a37c93090…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.